FTV Fortive Corporation
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.…
Industry Peers
Scientific & Technical InstrumentsKey Statistics
About Fortive (NYSE: FTV)
›
Fortive (NYSE: FTV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 10,000 employees.
The shares were at 64.16 USD on 20 November 2026, up 27.6% over 52 weeks. Its 52-week range is 50.09 USD to 68.94 USD: the price is 6.9% below the high and 28.1% above the low.
At a market capitalisation of 19.10B USD, it trades at 30.4 times trailing earnings and 19.3 times forward earnings. The median trailing P/E of its 19 largest Scientific & Technical Instruments peers is 28.8, so FTV is valued in line with them. It pays a dividend yielding 0.43% (it pays out 12% of its earnings), against a median of 1.05% among the dividend payers in that peer group.
Fortive reports return on equity of 9.0%, an operating margin of 19.6% and revenue up 7.8% year over year.
Its debt exceeds its cash by 3.22B USD, a debt-to-equity ratio of 0.51. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Hold; their mean price target of 67.50 USD is 5.2% above the current price. The next earnings report is expected on 3 February 2027.